To address this, we infected B7-H1KO mice intracranially with TMEV-OVA8 and treated mice with control IgG or anti-PD-1 antibody on day 3 post-infection and assessed the distribution of CD8+ and CD4+ T-cells in the CNS and spleen. The gene discussed is CD8A; the disease is infection.